Working in rare disease offers Medical Affairs professionals the opportunity to engage directly with patient organizations and researchers/HCPs deeply involved in providing new options for patients who lack current treatments. However, working in rare disease also comes with significant challenges. Here MAPS sits down at our 2022 Global Annual Meeting with Catherine Parham, Vice President and Head of Global Medical Affairs at Astellas Gene Therapies to talk about the unique position of Medical Affairs in the rare disease space — and how our work in this area is essential for patient benefit.
